Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRD1 | P41143 | 3/20 | 0.43 |
| ▸ | BACE1 | P56817 | 8/20 | 0.41 |
| ▸ | BACE2 | Q9Y5Z0 | 2/20 | 0.37 |
| ▸ | GLP1R | P43220 | 1/20 | 0.37 |
| ▸ | CTSD | P07339 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31721057 | 0.92 | OPRM1 (0.36) | OPRD1BACE1 | |
| SCHEMBL30799934 | 0.91 | BACE1 (0.45) | OPRD1BACE1BACE2CTSD | |
| SCHEMBL30254145 | 0.90 | OPRM1 (0.37) | OPRD1BACE1 | |
| SCHEMBL29430954 | 0.88 | OPRD1 (0.35) | OPRD1BACE1 | |
| SCHEMBL31514358 | 0.87 | MME (0.44) | BACE1BACE2GLP1R | |
| SCHEMBL30997434 | 0.86 | MME (0.38) | OPRD1BACE1BACE2 | |
| SCHEMBL30426633 | 0.86 | OPRD1 (0.35) | OPRD1BACE1 | |
| SCHEMBL30038078 | 0.85 | MME (0.39) | — | |
| SCHEMBL30254038 | 0.85 | BACE1 (0.38) | OPRD1BACE1CTSD | |
| SCHEMBL29598237 | 0.85 | MME (0.40) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025084719-A1 | PEPTIDE HAVING ACTIVITY OF SKIN WHITENING AND USES THEREOF | (주)케어젠 | 2025-04-24 | — | — | WO | disclosed |
| EP-4329827-A1 | TARGETING SYSTEM FOR CANCER COMPRISING A RADIOISOTOPE | Alphathera AG (CH) | 2024-03-06 | — | — | EP | disclosed |
| WO-2022231424-A1 | TARGETING SYSTEM FOR CANCER COMPRISING A RADIOISOTOPE | ALPHATHERA AG (CH) | 2022-11-03 | — | — | WO | disclosed |